Day: May 3, 2017

Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications

Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications

Current therapeutic approaches to depression fail for millions of patients due to lag in clinical response and non-adherence. Here we provide new support for the antidepressant effect of an anesthetic drug, ketamine, by Inverse-Frequency Analysis of eight million reports from the FDA Adverse Effect Reporting System. The results of the examination of population scale data...

MORE

Popular Blog Posts

“What will my ketamine infusion feel like?”

Ketamine therapy for OCD

At our Boulder Mind Care (in Boulder) and Transcendent Ketamine of Colorado (in Fort Collins), we provide dramatic relief…

LEARN MORE

The Denver Post features Transcendent Ketamine of Colorado & Boulder Mind Care December 24 2023

We were honored to be recently featured recently in The Denver Post, at https://www.denverpost.com/2022/12/24/ketamine-infusions-depression-chronic-pain-colorado. It is always beneficial when…

LEARN MORE

The Pandemic, Teen Depression, and Suicide Risk

Measures to contain the spread of coronavirus have inadvertently increased teen depression and suicide risk, as demonstrated by Mayne…

LEARN MORE

Ketamine Infusion Therapy for PTSD – Results of an Important New Study

A recent study[1] published in the January 5, 2021 American Journal of Psychiatry by Dr. Adriana Feder and her…

LEARN MORE

Ketamine – The Most Powerful Treatment For Depression Yet Invented

Ketamine continues to gain recognition, by both lay public and medical professionals, as a remarkably effective antidepressant, with minimal…

LEARN MORE